Global /Australia /Healthcare /Medical Devices /ADO
chevron_leftBack
AnteoTech Ltd. logo

AnteoTech Ltd.

ADO
ASX: ADO Delayed
0.0100AUD -9.1%
0.0071 USD
As of 5 June 2026, AnteoTech Ltd. has a market cap of $23.34M USD, ranking #36030 globally and #1013 in Australia. It ranks #3235 in the Healthcare sector, and #685 in the Medical Devices industry.
Global Rank
36030
Country Rank
1013
Sector Rank
3235
Industry Rank
685
Key Stats
Market Cap
$23.34MUSD
32.7M AUD
Enterprise Value
$23.48MUSD
32.9M AUD
Revenue (TTM)
$289.57KUSD
405.76K AUD
EBITDA (TTM)
-$3.96MUSD
-5.55M AUD
Net Income (TTM)
-$4.26MUSD
-5.97M AUD
PS Ratio
80.6
PB Ratio
16.1
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Merrill Gray open_in_new
Employees
99
Website
anteotech.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-9.1% -38% -8.3% -35% -42% 22%

News

Loading...

Markets

Exchange Ticker Price
Australian Securities Exchange
MIC: XASX
PRIMARY
ADO
AnteoTech Ltd
ISIN: AU000000ADO8
Shares Out.:
3.091B1 Shares Float: 3.084B2
TV:
SA:
YF:
GF:
BA:
ADO
MS:
0.0100 AUD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About AnteoTech Ltd.

AnteoTech Limited develops, manufactures, commercializes, and distributes products for clean energy technology and life science markets primarily in Australia, Asia, Europe, and North America. The company’s products include AnteoBind, a metal-ion complex-based activation technology that offers an alternative to conventionally used chemistries for the life sciences industry; AnteoBind NXT solution for the development of diagnostic tests; AnteoBind Micro and Micro Kit, a micro-particle-based assay development and bioseparation; AnteoBind Sub-Micron, Particle-based assay development, and bioseparation; AnteoBind Biosensor, a planar solid phase assay development; Activation Kit Multiplex Microspheres, an immunoassay development; and Nano Kit, a nanoparticle-based lateral flow assay development and bioseparation. It also provides AnteoX, an additive that reinforces battery binders that enhance performance of silicon containing anodes; and Ultranode, an ultra-high silicon anode design to offer high performance for lithium-ion batteries. In addition, the company offers contract services. The company was formerly known as Anteo Diagnostics Limited and changed its name to AnteoTech Limited in November 2019. AnteoTech Limited is headquartered in Eight Mile Plains, Australia.

Similar Companies

Industry: Medical Devices (Australia)
Name
Market Cap diff.
PE
COH
$4.2B
5.89B AUD
18K%
17.1
EBO
$2.55B
4.34B NZD
11K%
16.0
$786.34M
1.1B AUD
3K%
-
NAN
$743.12M
1.04B AUD
3K%
52.3
TTX
$171.0M
239.61M AUD
633%
-
OCC
$170.38M
238.75M AUD
630%
-
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
$173.27B
742K%
25.8
$160.73B
689K%
56.7
$159.07B
681K%
25.6
DHR
$126.55B
542K%
34.7
SYK
$120.69B
517K%
38.3
MDT
$101.9B
437K%
22.2
chevron_leftBack